-
-
Call more information
660-596-2224 -
Author: Claire Wallace Becker’s ASC Review Maryland Heights, Mo.-based Sentio Biosciences has earned a contract from API Innovation Center, a St. Louis nonprofit focused on strengthening the U.S. supply chain, to develop and produce two pharmaceutical drugs used for anesthesia, according to a Dec. 25 report from the St. Louis Business Journal. Sentio will produce propofol […]
Read MoreAuthor: Koski, Karlyn MEd ASA Monitor 89(1):p 26, January 2025. | Launched this year in collaboration with the ASA Charitable Foundation and VITAL WorkLife, ASA’s SafeHaven Program offers a variety of clinician well-being resources designed to address ASA members’ professional and personal challenges. One of those resources is the Parent Coaching program, offered through our partner VITAL […]
Read MoreAuthor: Francesca Mathewes Becker’s ASC Review In November 2024, CMS finalized a 94-cent (2.83%) conversion factor decrease from 2024. The physician fee schedule conversion factor for 2025 is $32.35, down from $33.29 in 2024. Physicians and medical groups have expressed concern over the decrease in reimbursements, sharing that year-over-year decreases are proving unsustainable for many. “There’s going […]
Read MoreAuthors: Patel, Rita M. MD, FASA et al ASA Monitor 89(1):p 17-18, January 2025. Anesthesiologists work in an environment in which every member is a cog in the wheel. A missing spoke could cause the entire cart to collapse. Hence, when we retire, or even step into a new role, it behooves us to prepare ourselves […]
Read MoreNIH-funded scientists uncover clues to precancer and tumor biology New insights from multiple studies provide critical information on how cancer tumors develop, spread, and respond to treatments. The 10 studies from the Human Tumor Atlas Network (HTAN), a National Institutes of Health (NIH)-funded Cancer MoonshotSM initiative to construct three-dimensional maps of human tumors, published across a […]
Read More